Tag: Welsh

$SEM Stock Drop Reminder: Select Medical Announces $16.50 per share Acquisition – BFA Law’s Investigation into the Board is Ongoing

Select Medical Announces $16.50 per share Acquisition – BFA Law’s Investigation into the Board is Ongoing

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Warsaw, Poland – June 03, 2026 – JJP Biologics, ("JJPBio" or the "Company") a clinical-stage, immune-focused biotech that engineers precision antibodies to correct derailed immune pathways that drive autoimmune diseases and cancer, today announces positive interim data from its ongoing Phase 1b trial evaluating nebaprubart, also known as JJP-1212, its investigational potential first-in-class anti-CD89 antagonist, in patients diagnosed with Linear IgA Disease (LAD), a rare autoantibody-mediated skin disease.

GovCIO, a Welsh, Carson, Anderson & Stowe Company, to Acquire SoldierPoint Digital Health, LLC

Acquisition of SoldierPoint Marks a Major Expansionfor GovCIO into the Veterans Health Administration FAIRFAX, Va., July 23, 2025 /PRNewswire/ -- GovCIO, LLC ("GovCIO") a leading...

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors

Cardiff, United Kingdom – 15 July 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today announces the appointment of Douglas E. Williams, Ph.D. as independent Chair of its Board of Directors. He takes over from Ruth McKernan, who retains her role on the Board as a Director and Interim Chief Executive Officer (CEO).

Innova completes sale of Wrexham Solar Park to Atrato Onsite Energy

Innova & Atrato close on 15MWp Wrexham Solar Park; energy sold to Welsh Water via 40-year PPA to power Five Fords site, with grid upgrades planned.

WCAS ANNOUNCES STRATEGIC GROWTH INVESTMENT IN AIA CONTRACT DOCUMENTS, THE GOLD STANDARD FOR RISK MANAGEMENT WITHIN THE CONSTRUCTION INDUSTRY

SAN FRANCISCO, July 8, 2025 /PRNewswire/ -- Welsh, Carson, Anderson & Stowe ("WCAS"), a leading private equity firm with a 45-year track record of building...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsWelsh

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

Defiance ETFs 宣布 Defiance Daily 2X Space ETF (SPCL) 在 Cboe BZX Exchange, Inc. 暂停交易

$100 No Deposit Bonus 200 Free Spins Real Money Casinos – All iGaming Experts Report Rising Demand for Free Spins Casinos

Tag: Welsh

$SEM Stock Drop Reminder: Select Medical Announces $16.50 per share Acquisition – BFA Law’s Investigation into the Board is Ongoing

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

GovCIO, a Welsh, Carson, Anderson & Stowe Company, to Acquire SoldierPoint Digital Health, LLC

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors

Innova completes sale of Wrexham Solar Park to Atrato Onsite Energy

WCAS ANNOUNCES STRATEGIC GROWTH INVESTMENT IN AIA CONTRACT DOCUMENTS, THE GOLD STANDARD FOR RISK MANAGEMENT WITHIN THE CONSTRUCTION INDUSTRY

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us